Literature DB >> 9350735

Inhibitory effects of polyoxyethylene stearate, PANTA, and neutral pH on growth of Mycobacterium genavense in BACTEC primary cultures.

L Realini1, P Van Der Stuyft, K De Ridder, B Hirschel, F Portaels.   

Abstract

We report on the influences of polyoxyethylene stearate (POES), PANTA, and pH on primary cultures of Mycobacterium genavense in BACTEC vials. As a model for primary cultures from tissue, seven different strains first isolated from AIDS patients (five from Switzerland and two from the United States) were inoculated into nude mice in order to obtain large amounts of bacilli to test different conditions simultaneously. Our results demonstrate that the size of the inoculum (10[6] acid-fast bacilli/vial), an acid pH (pH 6.0), and the absence of additives (POES and PANTA) significantly (P < 0.001) increased the probability of a successful culture in 1 month, considering growth index (GI) of > or =100 or a GI of > or =999 as criterion of success. In logistic regression analysis, all factors maintained a significant (P < 0.001) independent effect, and no interactions were observed between them. The best conditions for the primary cultures of M. genavense were the use of Middlebrook 7H12 medium at pH 6.0 without any additives.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350735      PMCID: PMC230063          DOI: 10.1128/jcm.35.11.2791-2794.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndrome.

Authors:  B Hirschel; H R Chang; N Mach; P F Piguet; J Cox; J D Piguet; M T Silva; L Larsson; P R Klatser; J E Thole
Journal:  N Engl J Med       Date:  1990-07-12       Impact factor: 91.245

2.  A method for counting acid-fast bacteria.

Authors:  C C Shepard; D H McRae
Journal:  Int J Lepr Other Mycobact Dis       Date:  1968 Jan-Mar

3.  Bacteriologic investigations of unusual mycobacteria isolated from immunocompromised patients.

Authors:  S H Siddiqi; A Laszlo; W R Butler; J O Kilburn
Journal:  Diagn Microbiol Infect Dis       Date:  1993 May-Jun       Impact factor: 2.803

4.  Growth of mycobacteria in relation to the pH of the medium.

Authors:  F Portaels; S R Pattyn
Journal:  Ann Microbiol (Paris)       Date:  1982 Sep-Oct

5.  Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test.

Authors:  M A Miller; L Thibert; F Desjardins; S H Siddiqi; A Dascal
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

6.  Disseminated "Mycobacterium genavense" infection in patients with AIDS.

Authors:  E C Böttger; A Teske; P Kirschner; S Bost; H R Chang; V Beer; B Hirschel
Journal:  Lancet       Date:  1992-07-11       Impact factor: 79.321

7.  Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients.

Authors:  M B Coyle; L C Carlson; C K Wallis; R B Leonard; V A Raisys; J O Kilburn; M Samadpour; E C Böttger
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

8.  Isolation of a fastidious Mycobacterium species from two AIDS patients.

Authors:  K Jackson; A Sievers; B C Ross; B Dwyer
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

9.  The effect of polyoxyethylene stearate (POES) on the growth of mycobacteria in radiometric 7H12 Middlebrook TB medium.

Authors:  R R Cutler; P Wilson; F V Clarke
Journal:  Tubercle       Date:  1987-09

10.  Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system.

Authors:  S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

View more
  7 in total

Review 1.  Nontuberculous mycobacteria infection in solid organ transplant recipients.

Authors:  C Piersimoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-07       Impact factor: 3.267

2.  Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists.

Authors:  V O Thomsen; U B Dragsted; J Bauer; K Fuursted; J Lundgren
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

3.  Development and validation of a liquid medium (M7H9C) for routine culture of Mycobacterium avium subsp. paratuberculosis to replace modified Bactec 12B medium.

Authors:  Richard J Whittington; Ann-Michele Whittington; Anna Waldron; Douglas J Begg; Kumi de Silva; Auriol C Purdie; Karren M Plain
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

4.  Microaerophilic conditions promote growth of Mycobacterium genavense.

Authors:  L Realini; K De Ridder; J Palomino; B Hirschel; F Portaels
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

5.  Rapid identification of Mycobacterium genavense with a new commercially available molecular test, INNO-LiPA MYCOBACTERIA v2.

Authors:  François Trueba; Michel Fabre; Patrick Saint-Blancard
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 6.  Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature.

Authors:  E Tortoli; F Brunello; A E Cagni; D Colombrita; D Dionisio; L Grisendi; V Manfrin; M Moroni; C Passerini Tosi; G Pinsi; C Scarparo; M T Simonetti
Journal:  Eur J Epidemiol       Date:  1998-04       Impact factor: 8.082

7.  Effect of 1.5% sodium hydroxide final concentration on recovery rate of Mycobacterial Species and decontamination of other Bacterial and Fungal contaminants on sputum.

Authors:  Desalegn Addise; Adane Bitew; Zelalem Yaregal; Bazezew Yenew; Helina Mollalign; Getu Diriba; Abebaw Kebede
Journal:  Ethiop J Public Health Nutr       Date:  2016
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.